Latest news with #Ophthalmology
Yahoo
15-05-2025
- Business
- Yahoo
India Ophthalmic Devices Market Forecast Report 2025-2033, Competitive Analysis of Alcon, Bausch Health, Carl Zeiss, Meditec, Essilor, Hoya, Johnson & Johnson, Nidek, Topcon
The India Ophthalmology Devices Market is set to grow from USD 661.10 million in 2024 to USD 1.12 billion by 2033, at a CAGR of 6.11%. Key drivers include the rising prevalence of eye diseases, an aging population, and technological advances in ophthalmic devices. Government initiatives and increased healthcare spending further propel growth, while high costs and a lack of trained professionals pose challenges. Regional differences show growth in East, North, and South India with varying access levels and infrastructure development. Indian Ophthalmic Devices Market Dublin, May 15, 2025 (GLOBE NEWSWIRE) -- The "India Ophthalmic Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to India Ophthalmology Devices Market is on a promising trajectory, projected to rise from USD 661.10 million in 2024 to USD 1.12 billion by 2033, expanding at a CAGR of 6.11% The surge is fueled by increasing eye disease incidences, the elders' growing demographic, and technological advancements in ophthalmic devices. Crucial drivers include the prevalence of cataracts, glaucoma, refractive errors, and diabetic retinopathy, escalating with an aging population and diabetes spread. Enhanced government measures like the National Programme for Control of Blindness (NPCB) and private investments in advancing ophthalmic technologies play pivotal roles. AI-enhanced diagnostics and teleophthalmology significantly extend access in rural regions, while awareness and cost reductions propel market demand. Significant market growth factors encompass the high occurrence of eye disorders in India and technological strides in ophthalmic equipment such as AI-based diagnostics, robotic surgeries, and advanced laser therapies. Breakthrough instruments like optical coherence tomography (OCT) and affordable intraocular lenses (IOLs) broaden the availability of cutting-edge ophthalmic care, enhancing early detection and treatment efficacy. C3 Med-Tech's investment in bringing AI-powered eye screening devices exemplifies such advancements. Government initiatives and rising healthcare investment are central to the market's expansion. The government drives accessibility through programs like the Ayushman Bharat scheme, sponsoring new ophthalmic facilities and insurance coverage increases. The 'Comprehensive Eye Care Programme' in Karnataka aims to benefit underprivileged populations, supported by efforts for innovative ocular devices and solutions. Challenges remain, with the high cost of advanced devices hindering widespread adoption, particularly in rural and semi-urban areas. Limited numbers of experienced ophthalmologists further dilute accessibility, although efforts in teleophthalmology and capacity-building persist. Within specific segments, the intraocular lenses market flourishes due to rising cataract surgeries, offering improved multifocal IOLs. Government initiatives for cost-effective IOLs and domestic production facilitate market growth against a backdrop of heightened cataract surgery awareness. The laser devices market benefits from precision surgeries like LASIK, despite the high costs, with technological development likely to spur future uptake. Demand for ophthalmoscopes and corneal topography systems escalates as conditions like diabetic retinopathy and keratoconus are diagnosed more frequently. Though cost and device availability challenge rural deployment, tech advancements push growth. Contact lenses enjoy increased demand for non-invasive vision correction, fueled by urban lifestyles and disposable income growth, even as educational gaps in lens care persist. The East, North, and South India markets each exhibit distinct growth patterns, supported by government investments, urban infrastructure, and renowned eye care institutions. Companies like Alcon Inc., Bausch Health Companies Inc., and Essilor International SA are instrumental market players deploying robust strategies across the ophthalmic landscape. As these trends unfold, the India Ophthalmology Devices Market is poised to significantly transform eye care services nationwide. Key Attributes: Report Attribute Details No. of Pages 200 Forecast Period 2024 - 2033 Estimated Market Value (USD) in 2024 $661.1 Million Forecasted Market Value (USD) by 2033 $1120 Million Compound Annual Growth Rate 6.1% Regions Covered India Key Topics Covered: 1. Introduction2. Research & Methodology3. Executive Summary4. Market Dynamics5. India Ophthalmic Devices Market6. Market Share7. Surgical Devices8. Diagnostic and Monitoring Devices9. Vision Correction Devices10. Region11. Porter's Five Analysis12. SWOT Analysis13. Company Analysis Alcon Inc. Bausch Health Companies Inc. Carl Zeiss Meditec AG Essilor International SA Hoya Corporation Johnson & Johnson Nidek Co. Ltd Topcon Corporation For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Indian Ophthalmic Devices Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Zawya
15-05-2025
- Health
- Zawya
Saudi Arabia hosts landmark Ophthalmology Meeting to advance (DME) and (RVO) Treatment
Under the title 'Holistic pro-Inflammatory Target for Sight (HITS)' the Ophthalmology Pivotal Meeting kicked off in Saudi Arabia on April 25, 2025, under the auspices of AbbVie, the global biopharmaceutical research and development company. This is a significant move to elevate the standard of care for various eye conditions like Diabetic Macular Edema (DME) and Retinal Vein Occlusion (RVO). More than 100 national and international ophthalmologists participated in the meeting, which included scientific lectures and in-depth workshops to leverage applied medical specialties in ophthalmology and optics, exchange knowledge and expertise, and help change perspectives on the best ways to improve patient outcomes. It also discussed treatment and management methods of these prevalent diseases. In his lecture, Dr. Mattias Iglicki, Consultant Ophthalmologist, Vitreoretinal Surgeon and Researcher from University of Buenos Aires, Argentina, praised the convening of this meeting, which is a good opportunity to discuss the latest advancements and clinical trials in the presence of this elite group of international retinal specialists, along with local experts. He explained that diabetic macular edema, which is often the result of high blood sugar levels in diabetics, accompanied with leaky blood vessels leading to swelling in the retina. On the other hand, retinal vein occlusion occurs when the retinal veins are blocked, causing fluid buildup and impaired vision. Both conditions are serious and require proactive management to prevent the disease from worsening. Dr. Iglicki emphasized that organizing such medical summits and conferences serves as a platform for sharing and disseminating the cutting-edge research and developments in treating eye diseases, especially DME and RVO, which are diseases whose rates are increasing with the increasing incidence of diabetes. This enables the attending ophthalmologists to implement these updates in their practices, which in turn advances treatment methods in the Kingdom of Saudi Arabia in accordance with the latest international recommendations and technologies, thus improving the lives of patients and alleviating their daily suffering. For his part, Dr. Ashraf Daoud, General Manager of AbbVie Saudi Arabia, pointed out that Saudi Arabia's hosting of such medical meetings and seminars reflects the Kingdom's interest in promoting medical education and exchanging scientific expertise between international and local physicians to highlight the most important scientific and medical developments and provide distinguished medical care. By organizing this congress, AbbVie underscores its commitment to enhancing patient outcomes through educational initiatives and collaboration among eye care professionals. Sharing knowledge and expertise at such events is crucial to our ongoing efforts to refine treatment strategies, improve patients' quality of life, and help make a real difference in their lives. About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio.
Zawya
15-05-2025
- Health
- Zawya
Saudi Arabia hosts landmark ophthalmology meeting to advance DME and RVO treatment
Under the title 'Holistic pro-Inflammatory Target for Sight (HITS)' the Ophthalmology Pivotal Meeting kicked off in Saudi Arabia on April 25, 2025, under the auspices of AbbVie, the global biopharmaceutical research and development company. This is a significant move to elevate the standard of care for various eye conditions like Diabetic Macular Edema (DME) and Retinal Vein Occlusion (RVO). More than 100 national and international ophthalmologists participated in the meeting, which included scientific lectures and in-depth workshops to leverage applied medical specialties in ophthalmology and optics, exchange knowledge and expertise, and help change perspectives on the best ways to improve patient outcomes. It also discussed treatment and management methods of these prevalent diseases. In his lecture, Dr. Mattias Iglicki, Consultant Ophthalmologist, Vitreoretinal Surgeon and Researcher from University of Buenos Aires, Argentina, praised the convening of this meeting, which is a good opportunity to discuss the latest advancements and clinical trials in the presence of this elite group of international retinal specialists, along with local experts. He explained that diabetic macular edema, which is often the result of high blood sugar levels in diabetics, accompanied with leaky blood vessels leading to swelling in the retina. On the other hand, retinal vein occlusion occurs when the retinal veins are blocked, causing fluid buildup and impaired vision. Both conditions are serious and require proactive management to prevent the disease from worsening. Dr. Iglicki emphasized that organizing such medical summits and conferences serves as a platform for sharing and disseminating the cutting-edge research and developments in treating eye diseases, especially DME and RVO, which are diseases whose rates are increasing with the increasing incidence of diabetes. This enables the attending ophthalmologists to implement these updates in their practices, which in turn advances treatment methods in the Kingdom of Saudi Arabia in accordance with the latest international recommendations and technologies, thus improving the lives of patients and alleviating their daily suffering. For his part, Dr. Ashraf Daoud, General Manager of AbbVie Saudi Arabia, pointed out that Saudi Arabia's hosting of such medical meetings and seminars reflects the Kingdom's interest in promoting medical education and exchanging scientific expertise between international and local physicians to highlight the most important scientific and medical developments and provide distinguished medical care. By organizing this congress, AbbVie underscores its commitment to enhancing patient outcomes through educational initiatives and collaboration among eye care professionals. Sharing knowledge and expertise at such events is crucial to our ongoing efforts to refine treatment strategies, improve patients' quality of life, and help make a real difference in their lives. About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.
Free Malaysia Today
10-05-2025
- Health
- Free Malaysia Today
Rising myopia in children: experts urge preventive measures
The shift to online learning during the pandemic has resulted in prolonged screen time, a primary factor affecting children's eye health. (Envato Elements pic) KUALA LUMPUR : The prevalence of myopia, or nearsightedness, among children is a growing concern worldwide, including in Malaysia. According to the World Health Organization, cases have surged significantly, particularly after the pandemic. The global health authority predicts that by 2050, half of the global population will have myopia, with 10% of them at risk of developing high myopia. The latter condition can lead to serious complications, including glaucoma, retinal detachment, and permanent vision impairment. The shift to online learning during the pandemic – a trend that continues today – has resulted in prolonged screen time for children. Beyond education, many also engage with digital devices for entertainment. Ophthalmology specialist Dr Pall Singh said countries such as China, Japan, and Singapore report myopia rates exceeding 80% among teenagers. He warned that Malaysia is on a similar trajectory unless preventive measures are implemented. Citing current data, Pall noted a significant rise in myopia prevalence among children, increasing from 9.8% at age seven to 34.4% by age 15. The expert in vitreoretinal, medical retina, neuro-ophthalmology and orbit disorders said the rise in myopia among Malaysian children is driven by several key factors, including genetics and lifestyle habits. Dr Pall Singh. 'One of the main factors affecting children's eye health is the widespread use of digital devices. Children now spend more time in front of smartphones, tablets and computers, whether for schoolwork or entertainment. 'When children spend too much time in front of screens, their eyes are exposed to blue light, which emits short wavelengths that can cause eye strain. Over time, this contributes to the progression of myopia,' he told Bernama. Pall noted that long hours of studying in school, especially in an education system that prioritises academic achievement, require children to spend extended periods reading, writing, and focusing on near objects – further increasing their risk of myopia. 'In Malaysia, the packed school schedule – including extra classes, tuition, and continuous homework assignments – indirectly reduces children's opportunities to take breaks from near-work tasks and receive natural light exposure, increasing their risk of developing myopia,' he said. Eye strain caused by prolonged screen use is worsened by the fact that children often do not follow proper rest routines. According to Pall, children tend to ignore early signs of strain, such as watery or irritated eyes, which can lead to nearsightedness. Regular checkups with optometrists is crucial to prevent children from facing more significant vision difficulties in the future. (Envato Elements pic) As such, it is important for parents and educators to be attentive to early signs of myopia, as early detection is key to preventing more severe vision problems in the future. 'Left unaddressed, nearsightedness can negatively impact a child's academic performance and daily life, as they may struggle to see the whiteboard or engage in outdoor activities freely,' he added. 'Every child should undergoes regular eye checkups at optometry clinics to detect myopia at an early stage.' Natural light, outdoor activities Meanwhile, Mohd Mursyid Arshad, director of the Co-Curriculum and Student Development Centre at Universiti Putra Malaysia, pointed out that the lack of exposure to natural light and outdoor activities also contributes to the development of myopia. He said research has shown that children who spend more time outdoors have a lower risk of myopia compared with those who spend more time indoors. This is because natural light signals the eyes to develop in a healthier way, stimulating the retina to developed in a more structured manner. Mohd Mursyid Arshad. 'As such, children who receive less natural light, especially at a young age, are more likely to develop myopia,' Mursyid stressed. He also highlighted that outdoor activities provide other benefits such as improving children's physical and mental health. Playing outdoors helps enhance motor coordination and social development, which positively impact overall growth. Educational institutions, therefore, have to play an active role in helping children reduce myopia risk by paying attention to the learning environment. Potential measures include ensuring classrooms have adequate lighting, and reducing reliance on digital devices for learning. Pall agreed, saying exposure to natural light for at least two hours daily can reduce myopia risk by 30-50%, as outdoor light is significantly brighter (10,000–100,000 lux) compared to classroom lighting (only about 500 lux). He also recommends that national education policies incorporate vision health into the curriculum, and enhance collaboration between schools and parents to help reduce screen time at home.
